Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer

Wednesday, October 21, 2026 12:00 AM

Conditions: Anaplastic Thyroid Carcinoma; Thyroid Cancer; Thyroid Carcinoma Interventions: Drug: Dabrafenib; Drug: Trametinib; Biological: Pembrolizumab; Radiation: Pulsed Stereotactic Ablative Radiotherapy; Device: Ethos Sponsors: Washington ...

Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2

Friday, October 23, 2026 12:00 AM

Conditions: SCHIZOPHRENIA 1 (Disorder); Schizo Affective Disorder; Healthy Adult Interventions: Behavioral: Motion Perception Task; Behavioral: Sine Wave Speech Task; Behavioral: Volatility Task; Behavioral: Choice Probabilistic Reversal ...

Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms

Monday, October 19, 2026 12:00 AM

Conditions: Neuroendocrine Neoplasm; Gastroenteropancreatic Neuroendocrine Neoplasm Interventions: Drug: Somatostatin Analogue(s) Sponsors: Washington University School of Medicine; Curium US LLC Not yet recruiting

The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.

Friday, October 16, 2026 12:00 AM

Conditions: Late Life Treatment Resistant Depression; Depression - Major Depressive Disorder; Treatment Resistant Depression Interventions: Drug: Aripiprazole Augmentation; Drug: Bupropion Augmentation Sponsors: Washington University School ...

Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health

Wednesday, October 21, 2026 12:00 AM

Conditions: Breast Cancer; Cancer of Breast Interventions: Behavioral: Patient navigator Sponsors: Washington University School of Medicine; National Comprehensive Cancer Network Recruiting

[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)

Wednesday, October 21, 2026 12:00 AM

Conditions: Metastatic Prostate Cancer; Prostate Cancer Interventions: Drug: 1-(4-(2-Fluoroethoxy)phenyl)-8,9-dihiydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one; Device: FTT-PET/CT; Diagnostic Test: EnhanceAR-Seq Sponsors: Washington University ...

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

Thursday, October 15, 2026 12:00 AM

Conditions: Kidney Transplant Recipient; Cutaneous Squamous Cell Carcinoma (CSCC); Advanced Cutaneous Squamous Cell Carcinoma; Kidney Transplant Interventions: Drug: Cemiplimab; Drug: Prednisone; Drug: Sirolimus; Drug: Cetuximab (EGFR ...

Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas

Tuesday, October 20, 2026 12:00 AM

Conditions: Glioblastoma; Glioblastoma, IDH-wildtype; Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Interventions: Device: NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy; Drug: Cemiplimab; Drug: Chemotherapy Sponsors: ...